As we anticipate a wave of biosimilar approvals in 2023, this webinar will review the current state of the biosimilar marketplace, early actions employers can take in preparation for impending changes, and specific employer considerations for increasing utilization of these medications. Presenters will cover the cost-savings potential of biosimilars, lessons learned from adoption in other countries, and how the role of rebates impacts biosimilars in the U.S. market.
Join us as we explore strategies for adoption, contracting and member utilization and hear leading employers discuss how the shifting biosimilars landscape may impact their 2023 strategy.
Location & Time
- Philip Ransdell, Senior Director of Benefits, Cracker Barrel Old Country Store
- Juliana M. Reed, Executive Director, The Biosimilars Forum
- Mike Jansen, Sr. Director U.S. Health & Wellbeing-Benefits, Walmart Inc.